Methods for treating b cell lymphoma using CD80-specific antibodies
US6893638B2 · kind B2 · utility
18Cited by
6References
5Claims
0Family size
Inventors
Key dates
| Filing date | Jan 12, 2001 |
| Grant date | May 17, 2005 |
| Priority date | — |
| Expiry date | Jan 12, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods for treating B cell lymphoma using CD80-specific antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.